JP Morgan Chase’s PepGen PEPG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.9K Sell
5,185
-56
-1% -$315 ﹤0.01% 6506
2025
Q4
$34.1K Buy
5,241
+3,066
+141% +$15.9K ﹤0.01% 6365
2025
Q3
$10K Sell
2,175
-8,660
-80% -$14K ﹤0.01% 6639
2025
Q2
$12K Buy
10,835
+780
+8% +$1.1K ﹤0.01% 6277
2025
Q1
$14.1K Sell
10,055
-21,232
-68% -$43.7K ﹤0.01% 6231
2024
Q4
$119K Buy
31,287
+4,676
+18% +$29.1K ﹤0.01% 5690
2024
Q3
$228K Buy
26,611
+19,786
+290% +$234K ﹤0.01% 5346
2024
Q2
$109K Sell
6,825
-8,657
-56% -$124K ﹤0.01% 5476
2024
Q1
$228K Buy
15,482
+5,339
+53% +$63.1K ﹤0.01% 5280
2023
Q4
$69K Sell
10,143
-818
-7% -$4.49K ﹤0.01% 5891
2023
Q3
$55.7K Buy
10,961
+2,200
+25% +$14K ﹤0.01% 5762
2023
Q2
$78.3K Sell
8,761
-3,486
-28% -$45.6K ﹤0.01% 5568
2023
Q1
$150K Buy
12,247
+3,771
+44% +$59K ﹤0.01% 5231
2022
Q4
$113K Buy
8,476
+3,285
+63% +$42.4K ﹤0.01% 5309
2022
Q3
$47K Buy
5,191
+736
+17% +$7.23K ﹤0.01% 5567
2022
Q2
$44K Buy
+4,455
New +$49.7K ﹤0.01% 5699

Other funds holding PEPG

JP Morgan Chase's PEPG Position: Q1 2026 in Review

JP Morgan Chase reduced its PepGen (PEPG) stake by 1.1% in Q1 2026, selling an estimated $315 and leaving 5,185 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6506.

JP Morgan Chase first reported a position in PEPG in Q2 2022 and has held it in 16 quarters since. The position peaked at $228K in Q1 2024. 93 funds tracked by Wall St. Rank hold PEPG as of Q1 2026.

  • JP Morgan Chase held 5,185 shares of PepGen worth $21.9K as of Q1 2026.
  • JP Morgan Chase sold 56 PepGen shares in Q1 2026, an estimated $315.
  • PepGen made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6506 holding.
  • JP Morgan Chase first reported a position in PepGen in Q2 2022 and has held it in 16 quarters since.
  • JP Morgan Chase's PepGen position peaked at $228K in Q1 2024.
  • 93 funds tracked by Wall St. Rank held PepGen as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.